Yom Majok
About Yom Majok
Yom Majok is a Research Associate at Asklepios BioPharmaceutical, Inc., where he has worked since 2020. He holds a Bachelor of Science in Biological Engineering with a bioprocess concentration from North Carolina State University, where he studied from 2015 to 2020.
Work at Asklepios BioPharmaceutical
Yom Majok has been employed at Asklepios BioPharmaceutical, Inc. (AskBio) as a Research Associate since 2020. In this role, he contributes to various research initiatives within the company, which specializes in gene therapy and biopharmaceutical development. His responsibilities include conducting experiments, analyzing data, and supporting the development of innovative therapeutic solutions.
Education and Expertise
Yom Majok earned a Bachelor of Science (BS) degree in Biological Engineering with a concentration in Bioprocess from North Carolina State University. His studies spanned from 2015 to 2020, equipping him with a solid foundation in biological systems and engineering principles. This educational background supports his current research activities in the biopharmaceutical field.
Previous Experience in Quality Assurance and Research
Prior to his current role, Yom Majok gained valuable experience through internships. He worked as a Quality Assurance/Validation Intern at Medicago for three months in 2018, where he focused on quality control processes. In 2019, he served as an R&D/Quality Assurance/Manufacturing Intern at Aurobindo Pharma USA, Inc. for three months, further enhancing his skills in research and development within the pharmaceutical industry.
Internship Experience
Yom Majok completed two significant internships that contributed to his professional development. At Medicago, he was involved in quality assurance tasks, which provided insight into regulatory compliance and product validation. His internship at Aurobindo Pharma USA, Inc. allowed him to work in a multifaceted role that included research and development, quality assurance, and manufacturing processes, broadening his understanding of the pharmaceutical sector.